Off-label prescribing driving pregabalin use 

A sharp rise in the uptake of pregabalin is believed to be driven by GPs and other specialists prescribing it outside of its TGA approved indications. About 1.4 million scripts were issued to 295,000 patients in the first 12 months after the anticonvulsant was listed on the PBS in March 2013 for refractory neuropathic pain, in line with ...

Already a member?

Login to keep reading.

© 2021 the limbic